DrugPatentWatch Database Preview
Piramal Critical Company Profile
What is the competitive landscape for PIRAMAL CRITICAL, and what generic and branded alternatives to PIRAMAL CRITICAL drugs are available?
PIRAMAL CRITICAL has six approved drugs.
Summary for Piramal Critical
| US Patents: | 0 |
| Tradenames: | 6 |
| Ingredients: | 6 |
| NDAs: | 6 |
Drugs and US Patents for Piramal Critical
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Piramal Critical | ENFLURANE | enflurane | LIQUID;INHALATION | 074396-001 | Jul 29, 1994 | DISCN | No | No | ➤ Sign Up | ➤ Sign Up | |||||
| Piramal Critical | GABLOFEN | baclofen | INJECTABLE;INTRATHECAL | 022462-001 | Nov 19, 2010 | AP | RX | No | No | ➤ Sign Up | ➤ Sign Up | ||||
| Piramal Critical | LEVOTHYROXINE SODIUM | levothyroxine sodium | POWDER;INTRAVENOUS | 206163-002 | Jun 29, 2016 | AP | RX | No | No | ➤ Sign Up | ➤ Sign Up | ||||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
Paragraph IV (Patent) Challenges for PIRAMAL CRITICAL drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | for Injection | 200 mcg/vial | ➤ Subscribe | 2015-05-01 |
| ➤ Subscribe | for Injection | 100 mcg/vial and 500 mcg/vial | ➤ Subscribe | 2015-04-14 |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
